QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Closes $28.6M Private Placement to Fund Long-Term Operating Plan

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has completed a private placement transaction resulting in aggregate gross proceeds of an estimated $28.6 million. After deducting placement agent fees and other offering expenses, capital from the transaction, along with existing balance sheet cash, will be used to fund DRIO’s long-term strategic operating plan. “We are pleased to have the confidence of our largest shareholder and several new highly regarded healthcare investors as we expand our commercial to manage existing and anticipated near-term agreements with health care payers,” said Dario CEO Erez Raphael, chief executive officer of Dario. “The adoption rate of digital therapeutics has been accelerated by the current pandemic. Dario’s efficacious, value-oriented solution is well-positioned to compete in this largely untapped U.S. market.”

To view the full press release, visit http://ibn.fm/NWe5K

About DarioHealth Corp.

DarioHealth is a leading, global, digital-therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the company empowers individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. The company’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario offers one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new geographic markets to address chronic conditions using a performance-based approach to improve the health of users managing chronic disease. For more information, visit the company’s website at www.DarioHealth.com

NOTE TO INVESTORS: The latest news and updates relating to DarioHealth are available in the company’s newsroom at http://ibn.fm/DRIO

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer

QualityStocksNewsBreaks – Hemptown Organics Corp. Featured on PPLive ProCapital

Hemptown Organics was featured on PPLive ProCapital, where the company’s CEO, Eric Gripentrog, presented Hemptown’s pitch for the hemp session. “Prohibition Partners actually projects the global legal cannabis market to be worth up to $104 billion by 2024,” Gripentrog stated. “These are staggering numbers with exponential growth every year, and we would like you to join our organization, which will ultimately become the global leader in this fast-growing industry… Our vision is to be the leading and the most innovative cannabinoid company within the industry with a mission of being fully integrated, which would include genetics, cultivation, processing, manufacturing, fulfillment, and brands.”

To view the full press release, visit http://ibn.fm/rSpBx

About Hemptown Organics Corp.

Hemptown is growing some of the finest hemp in the world to meet the global demand for cannabinoid-based products. State-of-the-art cultivation, product manufacturing capability and a strong leadership team are the pillars for Hemptown’s growth model as the Company pushes into the consumer packaged goods sectors with top quality white label and branded product lines for the consumer market. Hemptown’s fully operational (FDA-licensed and cGMP certified) nutraceutical manufacturing facility in Oregon gives the Company a strong leadership position in a global market that continues to grow exponentially. For more information, visit www.HemptownUSA.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) to Present at the SNN Network Virtual Investor Conference

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused waters and CBD-infused products, today announced that it will present at the SNN Network Virtual Investor Conference at 12:30 p.m. Eastern Time on Wednesday, August 5, 2020. According to the update, the company’s president and CEO, Ricky Wright, will host the presentation and answer questions from investors. Interested parties may register for the virtual event by visiting http://ibn.fm/2YRum .

To view the full press release, visit http://ibn.fm/PAleX

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label “Clean Beverage.” Quickly being recognized as a growing lifestyle brand, Alkaline88(R) launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused(TM) flavored water is available in seven unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested full-spectrum hemp salves, balms, lotions, essential oils, and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules, and gummies. To purchase A88CBD(TM) products online, visit www.A88CBD.com. To learn more about The Alkaline Water Company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Eyes Opportunity in Soon-To-Be $229.4B ‘Big Data’ Sector

SRAX (NASDAQ: SRAX), a provider of digital-marketing and consumer data-management technology solutions, provides next-gen tools for consumers and brands to communicate and monetize data – a commodity considered “big” by today’s standards. SRAX’s commercial prospects look especially promising with its positioning in the rapidly growing “Big Data” sector, set to hit $229.4 billion in 2025 (http://ibn.fm/vadIb). A recent article discussing SRAX’s innovative offerings reads, “SRAX’s BIGtoken platform has sought to capitalize on the growing demand for big data analytics through its broad user base as well as its extensive range of functionalities. Towards the end of 2019, the platform introduced the BIGtoken Lightning Insights functionality – a revolutionary tool which allows SRAX’s customers to instantly activate research and surveys about virtually any topic and pose it to BIGtoken’s extensive user base. Companies can choose to address their queries to BIGtoken’s extremely wide and diverse user base or opt to target extremely niche demographic and socio-economic sectors through the product’s over 25,000 points of segmentation and receive actionable audience insights within a matter of mere hours (http://ibn.fm/cDZYN).”

To view the full article, visit http://ibn.fm/pupp2

About SRAX

SRAX is a digital-marketing and consumer data-management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends, and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer

QualityStocksNewsBreaks – Sugarmade, Inc. (SGMD) Announces New Form 8K Highlighting Further Details on Performance and Outlook

Sugarmade (OTCQB: SGMD), today announced the publication of a new Form 8K Current Report filing (the “8K”) with the United States Securities and Exchange Commission (the “SEC”) highlighting specific information about multiple issues pertinent to its performance and outlook. According to the update, the 8K covers information about Sugarmade’s reported purchase orders for non-medical personal protective supplies, its progress toward opening multiple new locations for its cannabis delivery service in the Los Angeles regional market, its investment position in Indigo Dye Group, Inc (“Indigo’), and its outlook regarding the trends defining the California cannabis delivery marketplace.

To view the full press release, visit http://ibn.fm/biMKT

About Sugarmade, Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. More information on Sugarmade can be accessed at: www.Sugarmade.com. Sugarmade sees opportunities in business operations that combine the best areas of on-demand consumer distribution with certain areas of synergistic manufacturing and packaging to create a business model that capitalizes on the many changes in the cannabis industry. The company has made agreements with several market participants, which will be announced in 2020. The company views these opportunities as scalable and capable of producing strong revenue growth for the company.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer

The Movie Studio Inc. (MVES) Benefits as Film Libraries See Valuations Skyrocket

• Film libraries have become increasingly valuable in recent years with hundreds of millions of dollars being paid for film assets over last 12 months
• The Movie Studio has sought to augment its film library through purchase of various motion picture films in last 5 years
• Increasingly, VOD platforms and cable tv channels are competing to license unique film, tv show assets in bid to increase subscriber base
• With movie assets commanding higher licensing fees and sale prices, MVES is poised to benefit from revaluation of its film library assets

In late October 2019, Lakeshore Entertainment, a 25-year old independent film studio, agreed to the sale of its 300-title film and TV library and international sales operations to Vine Alternative Investments for a gross monetary consideration speculated to be around the $200 million mark (http://ibn.fm/LEGSz). Similarly, The Movie Studio (OTC: MVES), an independent motion picture production company based in Florida, has long based its business model on the purchase of legacy film libraries which have been upgraded to 4K resolution along with the re-monetization of new content on popular video on demand (“VOD”) streaming platforms. With film content and distribution rights becoming increasingly valuable as streaming platforms compete to attract viewers through the provision of unique licensed films and TV shows, The Movie Studio stands to benefit from the revaluation of its media library.

The Movie Studio has been an avid purchaser of film libraries over the past decade. In 2015, the company purchased a 60% stake in the Seven Arts film library, which included films by top Hollywood stars such as John Goodman, Ving Rhames, Burt Reynolds and Tim Robbins (http://ibn.fm/QeR0E). The purchase was followed up by a subsequent acquisition in 2016, with The Movie Studio arriving at an agreement to acquire a 12 major motion picture library from the Arrowhead Target Fund, including films such as “Johnny Mnemonic” starring Keanu Reeves, “Never Talk to Strangers” featuring Antonio Banderas, and Clive Owens’ “I’ll Sleep when I’m Dead” (http://ibn.fm/QbRvC).

The proliferation of streaming outlets and television channels seeking new content has led to a virtual ‘arms race’ in terms of licensing media content. “[Film] libraries run forever,” says Scott Kennedy, president of worldwide marketing and distribution at Forrest Films (http://ibn.fm/pm2fI). “As the studios launch their own streaming services and pull their films off Netflix and Amazon, those guys are going to be even more hungry for content.”

The rapid proliferation of new VOD platforms has meant that sellers can now license their film assets on multiple occasions, with major Hollywood film studios now attributing a significant portion of their revenues through licensing deals.  “In the U.S. now, we are selling our titles by the month,” said Chris Ottinger, president of worldwide television distribution and acquisitions at MGM. Ottinger added that the studio had witnessed double-digit growth in licensing sales for its back catalog across streaming VOD, premium and cable over the last 12 months. “It’s not uncommon to do 10 to 15 different licensing deals for a single title in a single territory.”

The Movie Studio has followed this trend, with the film studio’s latest releases available on platforms such as Showtime, Comcast, Amazon Prime and Tubi TV in addition to MVES’s foreign licensing deals, which has seen it already exclusively license several of its films for the territory of Australia over the past quarter (http://ibn.fm/owEPB).

With film libraries becoming increasingly valuable in today’s content driven market – most recently shown when ViacomCBS purchased a 49% stake in Miramax’s 700 film library for a record $375 million last December (http://ibn.fm/M1zUE), the Movie Studio’s commercial strategy has the company well-positioned to benefit as VOD platforms and cable television compete for their viewers’ attention.

For more information, visit the company’s website at www.TheMovieStudio.com.

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Pure Extract Technologies Inc. Exec Team Offers Decades of Impressive Experience; Represents Power, Intellect Behind Organization

• The private, plant-based extraction company boasts roster of leaders worth noting
• CEO served decade-plus in corporate leadership roles across the natural products, agriculture, cannabis sectors
• Team of qualified experts plus cutting-edge extraction technology means Pure Extracts is set for long-term strategic distribution, product innovation

If leaders are, as a Forbes article notes, “the power and intellect behind their organizations,” Pure Extract Technologies (“Pure Extracts”) is clearly a presence to be reckoned with. Led by an impressive team of individuals with decades of experience in their areas of expertise, the private, plant-based extraction company has a roster of leaders worth noting.

“Successful leaders,” the “Forbes” article states, “are the visionaries charged with steering their brand around pitfalls. They must know when to seize opportunities and how to rally employees to work hard toward their company’s goals” (http://ibn.fm/esk0O). The executive team at Pure Extract Technologies appears to do that — and much more.

At the helm of the Pure Extracts organization is CEO Ben Nikolaevsky. Nikolaevsky has garnered more than a decade of experience in corporate leadership roles across the natural products, agriculture and cannabis sectors. Under his leadership as president and CEO, Natura Naturals Inc., a private Canadian cannabis-licensed producer, was acquired by Tilray Inc. Before his stint at Natura, Nikolaevsky served as president and CEO of Blue Goose Capital Corp. In addition, Nikolaevsky has shouldered responsibilities as market vice president of national accounts at Canadian Imperial Bank of Commerce (“CIBC”) and as chief credit officer and capital markets manager at IBM Global Financing Canada.

As Pure Extracts founder and COO, Doug Benville has more than a decade of experience in the cannabis space, including as founder of Pure Pulls, one of the most-recognized extract brands in Canada. Highly proficient in cannabis cultivation, system operations and oil extraction, Benville has been with Pure Extracts since the company’s beginning.

Pure Extract’s vice president of business development Alexander Logie is a serial entrepreneur with 30-plus years of experience in the financial services sector. He co-founded Crane Capital and Mercury Capital, both of which were successfully acquired by asset-management firms. Most recently, Logie served as interim CFO, acting COO and senior vice president of business development at Natura Naturals Inc., a privately held licensed producer of cannabis, which was acquired by Tilray Inc. in 2019.

Andy Gauvin, vice president of sales for Pure Extracts, is an accomplished, bilingual, senior sales leader who has worked for more than three decades in the cannabis and beverage alcohol space. Most recently, Gauvin was vice president of sales at Natura Naturals, a start-up licensed cannabis producer. In that position, he built invaluable relationships with key provincial cannabis customers, created sales strategies and played an important role in product development. Previously, Gauvin served as vice president of sales, Canada, for Moosehead Breweries, where he developed a national sales strategy that leveraged unique aspects from each province and built a highly successful sales culture focused on results.

Shivani Bhatia heads up quality assurance for Pure Extracts. Prior to joining Pure Extracts, Bhatia served as a senior official at Whistler Medical Marijuana Corp., overseeing quality assurance work for two facilities. A Health Canada Security Cleared QA professional, Shivani established and enforced GPP, GMP and Quality Assurance standards. Shivani holds bachelor’s and master’s degrees in biotechnology and a post-graduate diploma in pharmaceutical research.

Pure Extracts, on the other hand, is ideally positioned to enter the space as an experienced producer. With a team of qualified experts and cutting-edge extraction technology, the company is set up for long-term strategic distribution and product innovation. Located near Whistler, British Columbia, the Company’s facility is built for EU-GMP certification, which allows for international sales and ensures the production of high-quality, high-purity formulations on a commercial scale.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) CEO Again Featured on ‘Big Biz Show,’ to Present at Proactive’s One2One Virtual Investor Forum

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, on Thursday announced participation by its chairman and CEO, Rodney Varner, in a second-round live interview on the “Big Biz Show,” an emmy-award winning nationally syndicated TV and radio show. A replay of the interview is available for viewing on the company’s website. In addition, Genprex today announced that it will present at the Proactive Investors One2One Virtual Event at 1:40 p.m. ET on August 4, 2020. Varner will deliver a company overview, provide updates on its product pipeline, including its lead drug candidate, GPX-001, and discuss the company’s preclinical diabetes gene therapy candidate that may have the potential to cure type 1 and type 2 diabetes. Interested parties may register for the event at http://ibn.fm/XsTbH.

To view the full press releases, visit http://ibn.fm/c5TxY and http://ibn.fm/lKFv8

About Genprex, Inc.

Genprex is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, “GPX-001” (“quaratusugene ozeplasmid”), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). GPX-001 has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. GPX-001 has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for GPX-001 for NSCLC in combination therapy with osimertinib (AstraZeneca’s “Tagrisso(R)”) for patients with “EFGR” mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer